Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

ConditionRenal Insufficiency, Chronic

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorCentre Hospitalier Universitaire de Nīmes

About this trial

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.

Eligibility criteria

Qualifiers

chronic kidney disease (stage >= 4)

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

3,375 Participants

are grouped into 1 trial group

Sponsors and collaborators

Centre Hospitalier Universitaire de Nīmes

Lead sponsor

Source ClinicalTrials.gov